U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Siremadlin

MORE DETAILS

0282IF4JC8

Status:
Investigational
Source:
NCT04116541: Phase 2 Interventional Recruiting Malignant Solid Tumor
(2020)
Source URL:
https://clinicaltrials.gov/ct2/show/NCT04116541
Class (Stereo):
CHEMICAL (ABSOLUTE)
Targets:
Tumour suppressor p53/oncoprotein Mdm2
6

Siremadlin Succinate

MORE DETAILS

0XPX99P4ZT

Status:
Investigational
Source:
NCT04116541: Phase 2 Interventional Recruiting Malignant Solid Tumor
(2020)
Source URL:
https://clinicaltrials.gov/ct2/show/NCT04116541
Class (Stereo):
CHEMICAL (ABSOLUTE)
Targets:
Tumour suppressor p53/oncoprotein Mdm2
6
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966